title: Unique functional properties of the APB sensitive and insensitive rod pathways signaling light decrements in mouse retinal ganglion cells.
abstract: Light decrements are mediated by two distinct groups of rod pathways in the dark-adapted retina that can be differentiated on the basis of their sensitivity to the glutamate agonist DL-2-amino-phosphonobutyric (APB). By means of the APB sensitive pathway, rods transmit light decrements via rod bipolar cells to AII amacrine cells, then to Off cone bipolar cells, which in turn innervate the dendrites of Off ganglion cells. APB hyperpolarizes rod bipolar cells, thus blocking this rod pathway. With APB insensitive pathways, rods either directly synapse onto Off cone bipolar cells, or rods pass light decrement signal to cones by gap junctions. In the present study, whole-cell patch-clamp recordings were made from ganglion cells in the dark-adapted mouse retina to investigate the functional properties of APB sensitive and insensitive rod pathways. The results revealed several clear-cut differences between the APB sensitive and APB insensitive rod pathways. The latency of Off responses to a flashing spot of light was significantly shorter for the APB insensitive pathways than those for the APB sensitive pathway. Moreover, Off responses of the APB insensitive pathways were found to be capable of following substantially higher stimulus frequencies. Nitric oxide was found to selectively block Off responses in the APB sensitive rod pathway. Collectively, these results provide evidence that the APB sensitive and insensitive rod pathways can convey different types of information signaling light decrements in the dark-adapted retina.
authors.affiliation: Department of Structural and Cellular Biology, School of Medicine, Tulane University, New Orleans, Louisiana 70112, USA. gwang@tulane.edu
authors.forename: Guo-Yong
authors.initials: GY
authors.lastname: Wang
mesh_terms: D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D003623:Dark Adaptation / Q000502:physiology; D004307:Dose-Response Relationship, Radiation; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology*; D066298:In Vitro Techniques; D008027:Light; D008564:Membrane Potentials / Q000187:drug effects / Q000528:radiation effects; D051379:Mice; D008810:Mice, Inbred C57BL; D018613:Microscopy, Confocal / Q000379:methods; D020030:Nitric Oxide Donors / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D010396:Penicillamine / Q000031:analogs & derivatives / Q000494:pharmacology; D010775:Photic Stimulation / Q000379:methods; D012160:Retina / Q000166:cytology; D012165:Retinal Ganglion Cells / Q000187:drug effects*; D017948:Retinal Rod Photoreceptor Cells / Q000187:drug effects / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects
chemical_list: D000613:Aminobutyrates; D018690:Excitatory Amino Acid Agonists; D020030:Nitric Oxide Donors; C110881:S-nitro-N-acetylpenicillamine; D010396:Penicillamine; C012729:2-amino-4-phosphonobutyric acid